In a murine model of advanced osteosarcoma, immune checkpoint inhibition with three antibodies—anti-Tim-3, anti-PD-L1, and anti-OX-86—in combination with tumour debulking surgery resulted in better overall survival and no lung metastases in survivors [207]. Here, CD274 is linked to osteosarcoma.